BioNexus Gene Lab Corp Balance Sheet
BioNexus Gene Lab Corp's total assets for Q1 2026 were $21.20M, an increase of 129.14% from the previous quarter. BGLC total liabilities were $13.11M for the fiscal quarter, a 1955.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.